Advertisement

Indian Journal of Gastroenterology

, Volume 33, Issue 1, pp 1–9 | Cite as

Complications of ERCP

  • Nalini M. Guda
  • Duvvuru Nageshwar Reddy
  • Ajay KumarEmail author
REVIEW ARTICLE

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) is performed commonly for therapy. Its role in pancreaticobiliary diagnostic imaging has significantly decreased over time. Despite advances in our knowledge of the risk factors, complications, (especially post-ERCP pancreatitis), remain a significant problem. This review highlights the risk factors as related to the patient, procedure and the endoscopist, and the possible means to prevent complications. The best way to avoid any complication is “to avoid any procedure where the indication is not strong” and especially to refrain from doing diagnostic ERCP when alternate noninvasive imaging such as magnetic resonance cholangiopancreatography is available.

Keywords

Adverse events Cholangitis Endoscopy Pancreatitis Perforation 

References

  1. 1.
    Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–18.PubMedCrossRefGoogle Scholar
  2. 2.
    Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Boender J, Nix GA, de Ridder MA, et al. Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate. Endoscopy. 1994;26:209–16.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol. 1994;89:327–33.PubMedGoogle Scholar
  5. 5.
    Christoforidis E, Goulimaris I, Kanellos I, Tsalis K, Demetriades C, Betsis D. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy. 2002;34:286–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Freeman ML, Nelson DB, Sherman S, et al. Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) study group. Gastrointest Endosc. 1999;49:580–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–34.PubMedCrossRefGoogle Scholar
  9. 9.
    Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59:845–64.PubMedCrossRefGoogle Scholar
  10. 10.
    Friedland S, Soetikno RM, Vandervoort J, Montes H, Tham T, Carr-Locke DL. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy. 2002;34:483–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Mehta SN, Pavone E, Barkun JS, Bouchard S, Barkun AN. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy. 1998;30:457–63.PubMedCrossRefGoogle Scholar
  13. 13.
    Rabenstein T, Schneider HT, Bulling D, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy. 2000;32:10–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology. 1991;101:1068–75.PubMedGoogle Scholar
  15. 15.
    Tzovaras G, Shukla P, Kow L, Mounkley D, Wilson T, Toouli J. What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography? Aust N Z J Surg. 2000;70:778–82.PubMedCrossRefGoogle Scholar
  16. 16.
    Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Newcomer MK, Jowell PS, Cotton PB. Underestimation of adverse events following ERCP: a prospective 30 day follow up study. Gastrointest Endosc. 1995; 41: 408. (Abstract).Google Scholar
  18. 18.
    Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002;56:488–95.PubMedCrossRefGoogle Scholar
  19. 19.
    Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol. 1999;94:387–90.PubMedCrossRefGoogle Scholar
  20. 20.
    Johnson GK, Geenen JE, Bedford RA, et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc. 1995;42:312–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Cheon YK, Cho KB, Watkins JL, et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc. 2007;65:385–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Patel R, Tarnasky P, Hennesst WS, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP Pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized trial. Gastrointest Endosc. 1999; 49, AB80. (Abstract).Google Scholar
  23. 23.
    Buscaglia JM, Simons BW, Prosser BJ, et al. Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model. Endoscopy. 2008;40:506–12.PubMedCrossRefGoogle Scholar
  24. 24.
    Elton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc. 1998;47:240–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Guda N, Freeman M. Only if needed and as minimally as possible. Animal model for post-ERCP pancreatitis: a step in the right direction. Endoscopy. 2008;40:521–2.PubMedCrossRefGoogle Scholar
  26. 26.
    Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35:830–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Goff JS. Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction. Am J Gastroenterol. 1995;90:586–9.PubMedGoogle Scholar
  28. 28.
    Cotton PB. Precut papillotomy—a risky technique for experts only. Gastrointest Endosc. 1989;35:578–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Cennamo V, Fuccio L, Repici A, et al. Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc. 2009;69 (3 Pt 1):473–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Rabenstein T, Ruppert T, Schneider HT, Hahn EG, Ell C. Benefits and risks of needle-knife papillotomy. Gastrointest Endosc. 1997;46:207–11.PubMedCrossRefGoogle Scholar
  31. 31.
    Sriram PV, Rao GV, Nageshwar Reddy D. The precut—when, where and how? A review. Endoscopy. 2003;35:S24–30.Google Scholar
  32. 32.
    Testoni PA, Giussani A, Vailati C, Testoni S, Di LM, Mariani A. Precut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone disease. Dig Liver Dis. 2011;43:792–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Vandervoort J, Carr-Locke DL. Needle-knife access papillotomy: an unfairly maligned technique? Endoscopy. 1996;28:365–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Harewood GC, Baron TH. An assessment of the learning curve for precut biliary sphincterotomy. Am J Gastroenterol. 2002;97:1708–12.PubMedCrossRefGoogle Scholar
  35. 35.
    Bergman JJ, Rauws EA, Fockens P, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet. 1997;349:1124–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Fujita N, Maguchi H, Komatsu Y, et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc. 2003;57:151–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Komatsu Y, Kawabe T, Toda N, et al. Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy. 1998;30:12–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Mathuna PM, White P, Clarke E, Merriman R, Lennon JR, Crowe J. Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc. 1995;42:468–74.PubMedCrossRefGoogle Scholar
  39. 39.
    Minami A, Nakatsu T, Uchida N, et al. Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function. Dig Dis Sci. 1995;40:2550–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Ochi Y, Mukawa K, Kiyosawa K, Akamatsu T. Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol. 1999;14:90–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Prat F, Fritsch J, Choury AD, Meduri B, Pelletier G, Buffet C. Endoscopic sphincteroclasy: a useful therapeutic tool for biliary endoscopy in Billroth II gastrectomy patients. Endoscopy. 1997;29:79–81.PubMedCrossRefGoogle Scholar
  42. 42.
    Ueno N, Ozawa Y. Pancreatitis induced by endoscopic balloon sphincter dilation and changes in serum amylase levels after the procedure. Gastrointest Endosc. 1999;49 (4 Pt 1):472–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Vlavianos P, Chopra K, Mandalia S, Anderson M, Thompson J, Westaby D. Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut. 2003;52:1165–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Arnold JC, Benz C, Martin WR, Adamek HE, Riemann JF. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy. 2001;33:563–7.PubMedCrossRefGoogle Scholar
  45. 45.
    DiSario JA, Freeman ML, Bjorkman DJ, MacMathuna P, Petersen B, Sherman S. Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: preliminary results. Gastrointest Endosc. 1997;45:AB129. (Abstract).Google Scholar
  46. 46.
    Heo JH, Kang DH, Jung HJ, et al. Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones. Gastrointest Endosc. 2007;66:720–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Jeong S, Ki SH, Lee DH, et al. Endoscopic large-balloon sphincteroplasty without preceding sphincterotomy for the removal of large bile duct stones: a preliminary study. Gastrointest Endosc. 2009;70:915–22.PubMedCrossRefGoogle Scholar
  48. 48.
    Teoh AY, Cheung FK, Hu B, et al. Randomized trial of endoscopic sphincterotomy with balloon dilation versus endoscopic sphincterotomy alone for removal of bile duct stones. Gastroenterology. 2013;144:341–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Catalano MF, Linder JD, Chak A, et al. Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc. 2004;59:225–32.PubMedCrossRefGoogle Scholar
  50. 50.
    Rolny P, Anderberg B, Ihse I, Lindstrom E, Olaison G, Arvill A. Pancreatitis after sphincter of Oddi manometry. Gut. 1990;31:821–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Sherman S, Troiano FP, Hawes RH, Lehman GA. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc. 1990;36:462–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Sherman S, Hawes RH, Troiano FP, Lehman GA. Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter. Gastrointest Endosc. 1992;38:347–50.PubMedCrossRefGoogle Scholar
  53. 53.
    Wehrmann T, Stergiou N, Schmitt T, Dietrich CF, Seifert H. Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique. Endoscopy. 2003;35:472–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Guda NM, Freeman ML. True culprit or guilt by association? Is sphincter of Oddi manometry the cause of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction, or is it the patients’ susceptibility? Rev Gastroenterol Disord. 2004;4:211–3.PubMedGoogle Scholar
  55. 55.
    Rabenstein T, Schneider HT, Nicklas M, et al. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc. 1999;50:628–36.PubMedCrossRefGoogle Scholar
  56. 56.
    Kapral C, Duller C, Wewalka F, Kerstan E, Vogel W, Schreiber F. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy. 2008;40:625–30.PubMedCrossRefGoogle Scholar
  57. 57.
    Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–47.PubMedCrossRefGoogle Scholar
  58. 58.
    Guda NM, Freeman ML. Are you safe for your patients—how many ERCPs should you be doing? Endoscopy. 2008;40:675–6.PubMedCrossRefGoogle Scholar
  59. 59.
    Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc. 2006;64:45–52.PubMedCrossRefGoogle Scholar
  60. 60.
    Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73:275–82.PubMedCrossRefGoogle Scholar
  61. 61.
    Freeman ML. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only? Gastrointest Endosc. 2010;71:940–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42:842–53.PubMedCrossRefGoogle Scholar
  63. 63.
    Sofuni A, Maguchi H, Mukai T, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol. 2011;9:851–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59:8–14.PubMedCrossRefGoogle Scholar
  65. 65.
    Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, Lehman GA. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol. 2004;2:322–9.Google Scholar
  66. 66.
    Chahal P, Tarnasky PR, Petersen BT, et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7:834–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Pahk A, Rigaux J, Poreddy V, Smith J, Al-Kawas F. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. Dig Dis Sci. 2011;56:3058–64.PubMedCrossRefGoogle Scholar
  68. 68.
    Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy. 2009;41:1095–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc. 1990;36:93–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Smith MT, Sherman S, Ikenberry SO, Hawes RH, Lehman GA. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc. 1996;44:268–75.PubMedCrossRefGoogle Scholar
  71. 71.
    Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2009;8:11–6.PubMedGoogle Scholar
  72. 72.
    Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Dumonceau JM, Rigaux J, Kahaleh M, Gomez CM, Vandermeeren A, Deviere J. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc. 2010;71:934–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Katsinelos P, Fasoulas K, Paroutoglou G, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy. 2012;44:53–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Ferreira LE, Baron TH. Post-sphincterotomy bleeding: who, what, when, and how. Am J Gastroenterol. 2007;102:2850–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc. 2002;56 Suppl 6:S273–82.Google Scholar
  77. 77.
    Howard TJ, Tan T, Lehman GA, et al. Classification and management of perforations complicating endoscopic sphincterotomy. Surgery. 1999;126:658–63.PubMedCrossRefGoogle Scholar
  78. 78.
    Baron TH, Gostout CJ, Herman L. Hemoclip repair of a sphincterotomy-induced duodenal perforation. Gastrointest Endosc. 2000;52:566–8.PubMedGoogle Scholar
  79. 79.
    Enns R, Eloubeidi MA, Mergener K, et al. ERCP-related perforations: risk factors and management. Endoscopy. 2002;34:293–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31–40.PubMedCrossRefGoogle Scholar
  81. 81.
    Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39:793–801.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2013

Authors and Affiliations

  • Nalini M. Guda
    • 1
  • Duvvuru Nageshwar Reddy
    • 2
  • Ajay Kumar
    • 3
    Email author
  1. 1.St. Luke’s Medical Center and University of Wisconsin School of Medicine and Public HealthMilwaukeeUSA
  2. 2.Asian Institute of GastroenterologyHyderabadIndia
  3. 3.Indraprastha Apollo HospitalNew DelhiIndia

Personalised recommendations